Skip to main content
. 2022 Dec 23;101(51):e32520. doi: 10.1097/MD.0000000000032520

Table 2.

The 3-year incidence of type 2 diabetes in subjects with and without SLE and the Cox model estimated hazard ratio for patients with SLE.

SLE (n = 6159) Non-SLE (n = 18,477) Adjusted HR (95% CI) P-value
Type 2 diabetes n (%) PYs Rate* Type 2 diabetes n (%) PYs Rate*
Overall analysis 206 (3.34) 15814.33 130.26 507 (2.74) 50,108.93 101.18 1.22 (1.04–1.44) .0179
Stratified analysis
Age (yr)
 20–34 42 (1.43) 7805.24 53.81 100 (1.13) 24,268.34 41.21 1.23 (0.85–1.78) .2672
 35–49 71 (3.52) 5210.63 136.26 155 (2.56) 16,491.81 93.99 1.29 (0.97–1.72) .0817
 50–64 53 (6.62) 1966.01 269.58 144 (5.99) 6324.26 227.69 1.05 (0.76–1.45) .7887
 ≥65 40 (9.88) 832.45 480.51 108 (8.89) 3024.52 357.08 1.20 (0.83–1.74) .3374
Gender
 Female 168 (3.10) 14022.09 119.81 419 (2.58) 44,128.54 94.95 1.21 (1.01–1.45) .0425
 Male 38 (5.10) 1792.24 212.03 88 (3.94) 5980.39 147.15 1.32 (0.89–1.96) .1623
Monthly income (NTD)
 <20,000 130 (3.54) 9448.11 137.59 281 (2.69) 28,717.17 97.85 1.36 (1.10–1.69) .0041
 20,000–40,000 57 (3.03) 4773.42 119.41 170 (2.90) 15,592.44 109.03 1.00 (0.74–1.35) .9822
 >40,000 19 (3.14) 1592.80 119.29 56 (2.59) 5799.32 96.56 1.18 (0.70–2.01) .5339
Comorbidity
 Hypertension 59 (8.93) 1501.91 392.83 103 (10.26) 2514.65 409.60 1.09 (0.78–1.52) .6025
 Hyperlipidemia 15 (7.81) 431.87 347.33 32 (10.32) 775.62 412.57 1.03 (0.54–1.97) .9228
 Coronary artery disease 14 (8.64) 338.76 413.27 23 (10.27) 557.07 412.87 1.04 (0.52–2.09) .9126
 Cerebrovascular accident 19 (10.80) 358.18 530.47 15 (10.87) 334.11 448.95 1.79 (0.86–3.73) .1209
 Chronic renal disease 6 (6.38) 180.16 333.04 4 (10.53) 83.04 481.67 0.62 (0.14–2.87) .5421

CI = confidence interval, HR = hazard ratio, NTD = New Taiwan Dollar, PYs = person-years, SLE = systemic lupus erythematosus.

*

Per 10,000 person-years.